| Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Efluelda TIV 0.5 mL | suspension injectable en seringue pré-remplie | suspension injectable en seringue pré-remplie (Haemagglutininum Influenzae a (H1N1) (Virus Souche A/victoria/4897/2022 (H1N1)-Like: Reassortant Virus Ivr-238 Derived from A/victoria/4897/2022) 60µg / 0.5ml, Haemagglutininum Influenzae a (H3N2) (Virus Souche A/thailand/8/2022 (H3N2)-Like: Reassortant Virus San-022 Derived from A/california/122/2022) 60µg / 0.5ml, Haemagglutininum Influenzae b (Virus Souche B/austria/1359417/2021-Like: Derived from B/michigan/01/2021 (Victoria Lineage) wild Type)) 60µg / 0.5ml) | J07BB02 | |
| 02 | Efluelda TIV 0.5 mL | suspension injectable en seringue pré-remplie | suspension injectable en seringue pré-remplie (Haemagglutininum Influenzae a (H1N1) (Virus Souche A/victoria/4897/2022 (H1N1)-Like: Reassortant Virus Ivr-238 Derived from A/victoria/4897/2022) 60µg / 0.5ml, Haemagglutininum Influenzae a (H3N2) (Virus Souche A/croatia/10136Rv/2023 (H3N2)-Like: Reassortant Virus X-425a Derived from A/croatia/10136Rv/2023) 60µg / 0.5ml, Haemagglutininum Influenzae b (Virus Souche B/austria/1359417/2021-Like: Derived from B/michigan/01/2021 (Victoria Lineage) wild Type)) 60µg / 0.5ml) | J07BB02 | |
